References to Primary Literature
- MONTO AS: Influenza: quantifying morbidity and mor-tality. Am. J. Med. (1987) 82:20–25.
- LUI K, KENDAL AP: Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am. J. Public Health (1987) 77:712–716.
- THE CENTERS FOR DISEASE CONTROL AND PREVENTION: Pneumonia and influenza death rates - United States, 1979-1994. JAMA (1995) 274:532.
- DOLIN R, REICHMAN RC, MADORE HP et al.: A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. New Engl. J. Med. (1982) 307:580–584.
- HALL CB, DOLIN R, GALA CL et al.: Children with influ-enza A infection: treatment with rimantadine. Pediatrics (1987) 80:275–282.
- GRUNNERT RR, MCGAHEN JW, DAVIES WL: The in vivo antiviral activity of 1-adamantanamine (amantadine). 1. Prophylactic and therapeutic activity against influ-enza viruses. Virology (1965) 26:262–269.
- HAYDEN FG, COTE KM, DOUGLAS RG, Jr.: Plaque inhibi-tion assay for drug susceptibility testing of influenza viruses. Antirnicrob. Agents Cbemotber. (1980) 17:865–870.
- BEISHE RB, BURK B, NEWMAN F, CERRUTI RL, SIM IS: Resistance of influenza A virus to amantadine and rinaantadine. Results of one decade of surveillance. J. Infect. Dis. (1989) 159:430–435.
- HAYDEN FG, BEISHE RB, CLOVER RD et al.: Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. New Engl. J. Med (1989) 321:1696–1702.
- GOTTSCHALK A, BHARGAVA AS: Neuraminidases. In: The Enzymes. Boyer PD (Ed.), Academic Press, New York (1971) 5:321–342.
- MEINDI P, BODO G, PALESE P, SCHU1MAN J, TUPPY H: Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology (1974) 58:457–463.
- PALESE P, SCHUIMAN JL, BODO G, MEINDI P: Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroace-tylneuraminic add (FANA). Virology (1974) 59:490–498.
- VARGHESE JN, LAVER WG, COLMAN PM: Structure of the Influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature (1983) 303:35–40.
- COLMAN PM: Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Sci. (1994) 3:1687–1696.
- VON ITZSTEIN M, WU W-Y, KOK GB et al.: Rational Inhibitors of potent sialidase-based inhibitors of influ-enza virus replication. Nature (1993) 363:418–423.
- WOODS JM, BETHELL RC, COATES JAV et al.: 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic add is a highly effective inhibitor of both the sialidase (neu-raminidase) and growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Cbemotber. (1993) 37:1473–1479.
- HAYDEN FG, TREANOR JJ, BETTS RF et al.: Safety and efficacy of the neuraminidase inhibitor 6G167 in ex-perimental human influenza. JAMA (1996) 275:295–299.
- BROSSMER R, MACK 11: The thiazoline ring as a protec-dve group of 2-amino-2-deoxy-3-thio-mannose. Tetra-bed. Lett. (1981) 22:933–936.
- MACK H, BROSSMER R: Synthesis of 6-thiosialic acids and6-thio-N-acetyl-D-neuraminic acid. Tetrahed. lett. (1987) 28:191–194.
- VON 1TZSTEIN M, J1N B, WU W-Y, CHANDLER M: A convenient method for the introduction of nitrogen and sulfur at C-4 on a sialic acid analogue. Carbohyd. Res. (1993) 244:181–185.
- POTTER M, MAMELI L, BELISLE M, DALLA1RE L, MELANCONSB: Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-a-D-N-acetylneuraminate) sub-strate. Ann. Biochern. (1979) 94:287–296.
- CHONG AK, PEGG MS, VON 1TZSTEIN M: Influenza virussialldase: effect of calcium on steady-state kinetic pa-rameters. Biochirn. Biophys. Acta (1991) 1077:65–71.
References to Patent Literature
- BIOTA SCIENTIFIC MANAGEMENT PTY. LTD., W09116320 (1991)